Avalon GloboCare Corp Dossier
Qualitative Analysis
Business overview
Avalon GloboCare Corp. (NASDAQ: ALBT) is a technology-innovation company strategically focused on developing and commercializing products and services for the consumer health and technology markets. The company operates through two primary business segments: Consumer Health Technology, which markets the FDA-registered KetoAir™ handheld breathalyzer device for ketogenic health management, and Artificial Intelligence Content Technology, which develops next-generation Agentic AI systems. Through its wholly-owned subsidiary, Avalon Quantum AI LLC, the company is advancing its 'Catch-Up' platform, a generative AI video production and small business marketing SaaS solution. Avalon has recently pivoted away from its legacy cellular therapy research and China-based laboratory services to focus resources on these high-growth AI and commercial diagnostic platforms.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Repositioning the company's core business model toward generative artificial intelligence through its subsidiary, Avalon Quantum AI, LLC. The initiative focuses on advancing the 'Catch-Up' SaaS platform from a manually configured tool into a fully autonomous agentic AI video system.
Expected impact: Enables non-technical content creators to generate personalized video content across multiple social media platforms, driving SaaS subscription revenue and expanding market reach.
Distributing and expanding the market presence of the KetoAir breathalyzer device, an FDA-registered Class I medical device that measures breath acetone concentration to track ketosis levels.
Expected impact: Establishes KetoAir as a key real-time tracking and accountability tool in preventative health and corporate wellness initiatives, driving device sales and software engagement.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Acquiring RPM Interactive brought the 'Catch-Up' generative AI video creation SaaS platform under Avalon's umbrella, serving as the cornerstone of Avalon's strategic pivot into artificial intelligence and forming its subsidiary, Avalon Quantum AI, LLC.
Financial impact: The transaction was executed via the issuance of 19,500 shares of Series E Non-Voting Convertible Preferred Stock (valued at $19.5 million), which successfully restored the company's stockholders' equity above the $2.5 million Nasdaq minimum requirement.
Strategic Partnerships
Collaborating to support Phase 2 development of the Catch-Up agentic AI video platform. Caylent (an AWS Premier Tier Consulting Partner) leads the development, leveraging AWS infrastructure to accelerate the platform's evolution into a fully autonomous agentic AI solution.
Terms: Terms of the collaboration were not publicly disclosed.
Integrating the KetoAir breathalyzer device into the Nevada POOL/PACT Holistic Health Reset program to support metabolic, physical, and behavioral wellness tracking for first responders.
Terms: Terms of the program integration were not publicly disclosed.